Study on the molecular mechanisms of tetrandrine against pulmonary fibrosis based on network pharmacology, molecular docking and experimental verification

Study on the molecular mechanisms of tetrandrine against pulmonary fibrosis based on network pharmacology, molecular docking and experimental verification

Aims: This study aims to screen the potential targets of tetrandrine (Tet) against pulmonary fibrosis (PF) based on network pharmacological analysis, molecular docking and experimental verification. Main methods: The network pharmacology methods were employed to predict targets, construct Tet-PF-int...

Full description

Bibliographic Details
Main Authors:	Jie Li, Yi Wang, Rui Wang, Meng-Yu Wu, Jing Shan, Ying-Chi Zhang, Hai-Ming Xu
Format:	Article
Language:	English
Published:	Elsevier 2022-08-01
Series:	Heliyon
Subjects:	Pulmonary fibrosis Tetrandrine Network pharmacology Target prediction Molecular docking Experimental verification
Online Access:	http://www.sciencedirect.com/science/article/pii/S240584402201489X

Similar Items

Preliminary Study on the Effect and Molecular Mechanism of Tetrandrine in Alleviating Pulmonary Inflammation and Fibrosis Induced by Silicon Dioxide
by: Yi Wang, et al.
Published: (2023-09-01)

Mechanism of Tetrandrine Against Endometrial Cancer Based on Network Pharmacology
by: Shang W, et al.
Published: (2021-07-01)

Tetrandrine slows the radiographic progression of progressive massive fibrosis in pneumoconiosis: a retrospective cohort study
by: Meian Tang, et al.
Published: (2023-08-01)

Tetrandrine Modulates Rheb-mTOR Signaling-Mediated Selective Autophagy and Protects Pulmonary Fibrosis
by: Yuanyuan Liu, et al.
Published: (2021-11-01)

Exploring the Underlying Mechanism of Alpinia officinarum Hance Ameliorating Diabetic Gastroparesis through Combining Network Pharmacology, Molecular Docking, and in Vivo Experimental Verification
by: Xiuwen Zheng, et al.
Published: (2023-08-01)

Research on the mechanism of berberine in the treatment of COVID-19 pneumonia pulmonary fibrosis using network pharmacology and molecular docking
by: Junfeng Cao, et al.
Published: (2022-05-01)

Mechanism of Qingchang compound against coccidiosis based on network pharmacology-molecular docking
by: Zhiqiang Yan, et al.
Published: (2024-03-01)

Network pharmacology based investigation on the mechanism of tetrandrine against breast cancer
by: Bhagya N
Published: (2023-02-01)

Potential Mechanism of Dingji Fumai Decoction Against Atrial Fibrillation Based on Network Pharmacology, Molecular Docking, and Experimental Verification Integration Strategy
by: Yi Liang, et al.
Published: (2021-11-01)

Analysis of the potential biological mechanisms of diosmin against renal fibrosis based on network pharmacology and molecular docking approach
by: Wen-Man Zhao, et al.
Published: (2023-05-01)

The Potential of Tetrandrine as a Protective Agent for Ischemic Stroke
by: Sheng-Hong Tseng, et al.
Published: (2011-09-01)

Tetrandrine alleviates oxaliplatin-induced mechanical allodynia via modulation of inflammation-related genes
by: Zhi-Ling Zhang, et al.
Published: (2024-02-01)

The underlying regulatory mechanisms of colorectal carcinoma by combining Vitexin and Aspirin: based on systems biology, molecular docking, molecular dynamics simulation, and in vitro study
by: Dengsheng Chen, et al.
Published: (2023-07-01)

Commentary: Potential Mechanism Prediction of Herbal Medicine for Pulmonary Fibrosis Associated With SARS-CoV-2 Infection Based on Network Analysis and Molecular Docking
by: Congchao Jia, et al.
Published: (2021-11-01)

Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL
by: Jiarui Li, et al.
Published: (2022-11-01)

Network Pharmacology and Experimental Verification Reveal the Regulatory Mechanism of Chuanbeimu in Treating Chronic Obstructive Pulmonary Disease
by: Xian M, et al.
Published: (2024-03-01)

Combinational study with network pharmacology, molecular docking and preliminary experiments on exploring common mechanisms underlying the effects of weijing decoction on various pulmonary diseases
by: Jia-Xin Li, et al.
Published: (2023-05-01)

Tetrandrine Inhibits Skeletal Muscle Differentiation by Blocking Autophagic Flux
by: Jing Li, et al.
Published: (2022-07-01)

Exploring the Mechanism Whereby Sinensetin Delays the Progression of Pulmonary Fibrosis Based on Network Pharmacology and Pulmonary Fibrosis Models
by: Yong Xu, et al.
Published: (2021-06-01)

Mechanisms underlying the activity of paederus in hepatocellular carcinoma: A network pharmacology and in vitro validation approach
by: Li shan, et al.
Published: (2022-06-01)

Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Aloin Against Gastric Cancer
by: Gao J, et al.
Published: (2022-06-01)

A Worldwide Bibliometric Analysis of Tetrandrine Research in Recent Two Decades
by: Guang Yang, et al.
Published: (2022-06-01)

Evaluation of the Molecular Mechanism of Chlorogenic Acid in the Treatment of Pulmonary Arterial Hypertension Based on Analysis Network Pharmacology and Molecular Docking
by: Jovito Cesar Santos-Álvarez, et al.
Published: (2024-01-01)

Tetrandrine suppresses cervical cancer growth by inducing apoptosis in vitro and in vivo
by: Zhang H, et al.
Published: (2018-12-01)

Alternation of Organ-Specific Exposure in LPS-Induced Pneumonia Mice after the Inhalation of Tetrandrine Is Governed by Metabolizing Enzyme Suppression and Lysosomal Trapping
by: Furun Wang, et al.
Published: (2022-10-01)

Progress on structural modification of Tetrandrine with wide range of pharmacological activities
by: Liuying Mo, et al.
Published: (2022-08-01)

Exploration of the effect and potential mechanism of quercetin in repairing spinal cord injury based on network pharmacology and in vivo experimental verification
by: Wenyuan Shen, et al.
Published: (2023-09-01)

Mechanisms predictive of Tibetan Medicine Sophora moorcroftiana alkaloids for treatment of lung cancer based on the network pharmacology and molecular docking
by: Peng Ji, et al.
Published: (2024-01-01)

Tetrandrine Prevents Neomycin-Induced Ototoxicity by Promoting Steroid Biosynthesis
by: Qilei Zhang, et al.
Published: (2022-04-01)

Mechanism of mingjing granules in treating wet age-related macular degeneration based on network pharmacology and experimental verification
by: Xiao-Yu Li, et al.
Published: (2024-01-01)

Tetrandrine suppresses proliferation, induces apoptosis, and inhibits migration and invasion in human prostate cancer cells
by: Wei Liu, et al.
Published: (2015-01-01)

Identification and validation of targets of swertiamarin on idiopathic pulmonary fibrosis through bioinformatics and molecular docking-based approach
by: Jun Chang, et al.
Published: (2023-10-01)

Network Pharmacology and Molecular Docking Reveal the Mechanism of Isodon ternifolius (D. Don) Kudo Against Liver Fibrosis
by: Deng J, et al.
Published: (2023-08-01)

Network pharmacology combined with molecular docking and experimental validation to reveal the pharmacological mechanism of naringin against renal fibrosis
by: Zhong Yanan, et al.
Published: (2023-06-01)

Preparation, Characterization, and Anti-Lung Cancer Activity of Tetrandrine-Loaded Stealth Liposomes
by: Fang Z, et al.
Published: (2024-01-01)

A Novel Tetrandrine-Loaded Chitosan Microsphere: Characterization and in vivo Evaluation [Retraction]
by: Guo K, et al.
Published: (2022-11-01)

Network Pharmacology and Molecular Docking Analysis Reveal Insights into the Molecular Mechanism of Shengma-Gegen Decoction on Monkeypox
by: Liujiang Dai, et al.
Published: (2022-11-01)

Tetrandrine sensitizes nasopharyngeal carcinoma cells to irradiation by inducing autophagy and inhibiting MEK/ERK pathway
by: Jun Wang, et al.
Published: (2020-10-01)

Uncovering the mechanism of resveratrol in the treatment of diabetic kidney disease based on network pharmacology, molecular docking, and experimental validation
by: Shengnan Chen, et al.
Published: (2023-06-01)

Integrated Network Pharmacology Analysis and Experimental Validation to Investigate the Molecular Mechanism of Triptolide in the Treatment of Membranous Nephropathy
by: Zhang PN, et al.
Published: (2022-11-01)